HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy. - Test2 - elhamkhani - TriplyDB

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

http://www.wikidata.org/entity/Q35175294

about

Profile of veliparib and its potential in the treatment of solid tumors Bi-phasic expression of Heterochromatin Protein 1 (HP1) during breast cancer progression: Potential roles of HP1 and chromatin structure in tumorigenesis.Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis Cell Mechanosensitivity is Enabled by the LINC Nuclear Complex.Downregulation of HP1α suppresses proliferation of cholangiocarcinoma by restoring SFRP1 expression.Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.Protein biomarkers for subtyping breast cancer and implications for future research.Prognostic values of distinct CBX family members in breast cancer.

P2860

Q26801272-6B2ED722-DBF3-4A0E-9FAC-B72F2DEA2623 Q35737313-2DBCC48A-9FE5-46D8-9D51-9DC6BC317AB3 Q36284245-69ED3590-F764-4D6C-BD7C-C76FC6A787E5 Q37016154-E86E0EE8-1FCD-46AE-A3CD-E59867AEA3DE Q37565399-542EE94C-2245-4601-AB14-22EEA389E74A Q42648237-1EFC9103-4B01-4E3B-A672-FE01D8F132EF Q47261659-81B56EED-5FA4-4779-AE00-38F3EFEFAB96 Q47346240-A67A07A5-B583-437F-B580-742CCBBD25B3

P2860

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

http://www.wikidata.org/entity/Q35175294

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@ast

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@en

type

label

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@ast

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@en

prefLabel

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@ast

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@en

P1433

Q35175294-563737CE-2D9E-49F7-8C98-901138AAE7E3

P1476

Q35175294-C0E14FED-FAD9-4307-9BEF-821C9DD383C5

P2093

Q35175294-032ECAC2-8F29-4DA4-B834-75E3F9569426

Q35175294-4D521099-4184-4B08-9A28-757D7102E5FC

Q35175294-579BC058-2462-44D3-9CE9-067210AE2CB6

Q35175294-D61AE4FE-779B-4565-8FA8-DB71390C8D97

Q35175294-E339D7E2-250C-4CEC-93B7-84EB20D45F89

P2860

Q35175294-0BCAE07B-46B7-4AF6-AC8E-D8D52BA373BF

Q35175294-0D60156B-6F94-48BC-A82C-1A503911B52A

Q35175294-0EA3E4C7-E5D3-4369-B0ED-8C0C342BA145

Q35175294-18FBA19B-7503-48BB-A9BC-9741A9E04EA7

Q35175294-1EA45382-8694-4738-9678-84C5568E488E

Q35175294-20E22B3F-73A4-48F5-B0F7-03658F404058

Q35175294-2BF35D67-B67A-42F5-8919-6C89A36DBE50

Q35175294-30CE8466-100D-4451-B464-44025169F5A1

Q35175294-34C79133-B3D7-4CDE-B3A6-E6208BCFCB0E

Q35175294-3B0712D7-142D-4837-9685-0BD68982BC43

P304

Q35175294-B69989A0-0521-46AD-9C49-6309DA1C4BCA

P31

Q35175294-8A12C832-8C11-4405-8248-D8A5AA221973

P356

Q35175294-33DD0158-C3A5-46A5-939E-2985A8A68C7B

P407

Q35175294-57718F00-3308-40BB-9902-92014A8E3E26

P433

Q35175294-6365D307-DA65-45CD-BED9-ED583FC26D3A

P478

Q35175294-F744E14B-6544-4C23-8A55-6D032174E526

P50

Q35175294-D3F825F2-2D2C-461A-8233-D878AAC9817E

P577

Q35175294-31046033-B909-469A-8CFC-1C6B596E8818

P5875

Q35175294-AB00B65B-B406-47DD-8D7A-274E3532EFDF

P698

Q35175294-291F6B43-B68E-4B1A-95F7-F1FF98242763

P921

Q35175294-1B268F62-DA12-4E95-A794-42C52138354F

P932

Q35175294-C7037702-917A-44A9-B8A2-5B6A06C3BF76

P356

JOURNAL.PONE.0121207

P1433

P1476

HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.

@en

P2093

David K Ann

http://www.w3.org/2001/XMLSchema#string

Fuming Qiu

http://www.w3.org/2001/XMLSchema#string

Timothy R O'Connor

http://www.w3.org/2001/XMLSchema#string

Young-Ho Lee

http://www.w3.org/2001/XMLSchema#string

Yun Yen

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive molecular portraits of human breast tumours

BRCAness: finding the Achilles heel in ovarian cancer

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Gene expression profiling predicts clinical outcome of breast cancer

A gene-expression signature as a predictor of survival in breast cancer

Molecular portraits of human breast tumours

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

The Ki-67 protein: from the known and the unknown

P304

e0121207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0121207

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273576296

http://www.w3.org/2001/XMLSchema#string

P698

25769025

http://www.w3.org/2001/XMLSchema#string

P921

P932

4358987

http://www.w3.org/2001/XMLSchema#string